Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Anti-Myeloma Activity of a Syringolin Analog: A Dual 20S Proteasome Inhibitor of Beta 2 and 5 Subunits

Takashi Yoshida, MD, Masaki Ri, MD PhD, Shiori Kinoshita, MD, Tomoko Narita, MD PhD, Haruhito Totani, MD, Reham Ashour, MD, Ayako Masaki, MD PhD, Asahi Ito, MD PhD, Shigeru Kusumoto, MD PhD, Takashi Ishida, MD PhD, Hirokazu Komatsu, MD PhD, Satoshi Ichikawa, Ph, PhD, Shinsuke Iida, MD PhD

Blood (2016) 128 (22): 4473.

https://doi.org/10.1182/blood.V128.22.4473.4473

Published: 2016

Journal Articles

Monitoring of Adult T-Cell Leukemia-Lymphoma Cells in Patients Receiving Mogamulizumab, a Humanized Anti-CCR4 Monoclonal Antibody, Using T-Cell Receptor Repertoire Analysis

Masato Saito, Takashi Ishida, MD PhD, Itaru Urakawa, PhD, Toshihiko Ishii, Asahi Ito, MD PhD, Ayako Masaki, MD PhD, Susumu Suzuki, PhD, Shigeru Kusumoto, MD PhD, Hirokazu Komatsu, MD PhD, Hiroshi Inagaki, MD PhD, Takeshi Takahashi, PhD, Ryuzo Ueda, MD PhD, Shinsuke Iida, MD PhD

Blood (2016) 128 (22): 1744.

https://doi.org/10.1182/blood.V128.22.1744.1744

Published: 2016

Journal Articles

Identification of Circulating Serum microRNAs As Novel Biomarkers Predicting Disease Progression and Sensitivity to Bortezomib Treatment in Multiple Myeloma

Tomoko Narita, MD PhD, Masaki Ri, MD PhD, Shiori Kinoshita, MD, Takashi Yoshida, MD, Haruhito Totani, MD, Reham Ashour, MD, Ayako Masaki, MD PhD, Asahi Ito, MD PhD, Shigeru Kusumoto, MD PhD, Takashi Ishida, MD PhD, Hirokazu Komatsu, MD PhD, Makoto Osabe, PhD, Masahiro Tohkin, PhD, Shinsuke Iida, MD PhD

Blood (2016) 128 (22): 4408.

https://doi.org/10.1182/blood.V128.22.4408.4408

Published: 2016

Journal Articles

Reduced Expression of HDAC3 Contributes to the Resistance Against HDAC Inhibitor, Vorinostat (SAHA) in Mature Lymphoid Malignancies

Jianming (Diane) Ding, MD, PhD, Masaki Ri, MD, PhD, Tomoko Narita, MD, Ayako Masaki, MD, Fumiko Mori, MD, Asahi Ito, MD, PhD, Shigeru Kusumoto, MD, PhD, Takashi Ishida, MD, PhD, Hirokazu Komatsu, MD, PhD, Yukimasa Shiotsu, PhD, Akio Niimi, MD, PhD, Shinsuke Iida, MD, PhD

Blood (2012) 120 (21): 1342.

https://doi.org/10.1182/blood.V120.21.1342.1342

Published: 2012

Journal Articles

Identification of Toyocamycin, an Agent Cytotoxic for Multiple Myeloma Cells, As a Potent Inhibitor of ER Stress-Induced XBP1 mRNA Splicing

Blood (2012) 120 (21): 5034.

https://doi.org/10.1182/blood.V120.21.5034.5034

Published: 2012

Journal Articles

A Randomized Trial Comparing Individualized Vs. Non-Individualized Treatment for Elderly Acute Myeloid Leukemia: JALSG GML200 Study

Atsushi Wakita, MD, Shigeki Ohtake, MD, Satoru Takada, MD, Fumiharu Yagasaki, MD, Hirokazu Komatsu, MD, Yasushi Miyazaki, MD, Koumei Kubo, MD, Yukihiko Kimura, MD, Akihiro Takeshita, MD, Yoko Adachi, MD, Hitoshi Kiyoi, MD, Takuhiro Yamaguchi, PhD, Minoru Yoshida, MD, Kazunori Ohnishi, MD, Shuichi Miyawaki, MD, Tomoki Naoe, MD, Ryuzo Ueda, MD, Ryuzo Ohno, MD

Blood (2008) 112 (11): 2961.

https://doi.org/10.1182/blood.V112.11.2961.2961

Published: 2008

Journal Articles

Mutational Analysis of Thrombopietin, c-MPL and Jak2 Genes in Essential Thrombothethymia Patients - Identification of Concurrent Mutations of c-MPL and Jak2.

Jianmin Ding, PhD, Hirokazu Komatsu, MD, Ph.D, Shinsuke Iida, MD, Ph.D, Asahi Ito, MD, Hiroki Yano, MD, Masaki Ri, MD, Atsushi Inagaki, MD, Ph.D, Shigeru Kusumoto, MD, Ph.D, Takashi Ishida, MD, Ph.D, Masakazu Nitta, MD, Ph.D, Ryuzo Ueda, MD, Ph.D

Blood (2007) 110 (11): 4658.

https://doi.org/10.1182/blood.V110.11.4658.4658

Published: 2007

Journal Articles

Asn 505 Mutation of the C-MPL Gene, A Cause of Familial Essential Thrombocythemia, Induces the Autonomous Homodimerizaton of the C-Mpl Independent of Ligand Stimulation.

Jianmin Ding, MD, Hirokazu Komatsu, MD, Shinsuke Iida, MD, Atsushi Wakita, MD, Masakazu Nitta, MD, Hiroshi Miyazaki, PhD, Ryuzo Ueda, MD

Blood (2004) 104 (11): 738.

https://doi.org/10.1182/blood.V104.11.738.738

Published: 2004

NARROW

Anti-Myeloma Activity of a Syringolin Analog: A Dual 20S Proteasome Inhibitor of Beta 2 and 5 Subunits

Monitoring of Adult T-Cell Leukemia-Lymphoma Cells in Patients Receiving Mogamulizumab, a Humanized Anti-CCR4 Monoclonal Antibody, Using T-Cell Receptor Repertoire Analysis

Identification of Circulating Serum microRNAs As Novel Biomarkers Predicting Disease Progression and Sensitivity to Bortezomib Treatment in Multiple Myeloma

Reduced Expression of HDAC3 Contributes to the Resistance Against HDAC Inhibitor, Vorinostat (SAHA) in Mature Lymphoid Malignancies

Identification of Toyocamycin, an Agent Cytotoxic for Multiple Myeloma Cells, As a Potent Inhibitor of ER Stress-Induced XBP1 mRNA Splicing

A Randomized Trial Comparing Individualized Vs. Non-Individualized Treatment for Elderly Acute Myeloid Leukemia: JALSG GML200 Study

Mutational Analysis of Thrombopietin, c-MPL and Jak2 Genes in Essential Thrombothethymia Patients - Identification of Concurrent Mutations of c-MPL and Jak2.

Asn 505 Mutation of the C-MPL Gene, A Cause of Familial Essential Thrombocythemia, Induces the Autonomous Homodimerizaton of the C-Mpl Independent of Ligand Stimulation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only